Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions

Transplant Immunology

Volumn 17, Issue 3, 2007, Pages 193-197

  Huang, Xiao Jun ^a   Chang, Ying Jun ^a   Zhao, Xiang Yu ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Bone marrow grafts; Dendritic cells; Granulocyte colony stimulating factor; Peripheral blood stem cells grafts; T cell

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 4; MONOTETRAZOLIUM; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; BONE MARROW TRANSPLANTATION; CELL POLARITY; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MIXED CELL CULTURE; MONOCYTE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN SECRETION; STEADY STATE; T LYMPHOCYTE;

BONE MARROW TRANSPLANTATION; CELL PROLIFERATION; DENDRITIC CELLS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL MOBILIZATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; LYMPHOCYTE ACTIVATION; MONOCYTES; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 33847222758     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2006.10.002     Document Type: Article

References (19)

1. Brensinger W.I., Clift R.A., Anasetti C., Appelbaum F.A., Demirer T., Rowley S., et al. Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte-colony stimulating factor. Stem Cells 14 (1996) 90
2. Morton J., Hutchins H., and Durrant S. Granulocyte-colony-stimulating factor (G-CSF)-primed allogeneic bone marrow: significantly less graft-versus-host disease and comparable engraftment to G-CSF-mobilized peripheral blood stem cells. Blood 98 (2001) 3186-3191
3. Elfenbein G.J., and Sackatein R. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow. Exp Hematol 32 (2004) 327-339
4. Isola L., Scigliano E., and Fruchtman S. Long-term follow-up after allogeneic granulocyte colony-stimulating factor-primed bone marrow transplantation. Biol Blood Marrow Transplant 6 (2000) 428-433
5. Chen S.H., Li X., and Huang X.J. Effect of recombinant human granulocyte colony-stimulating factor on T-lymphocyte function and the mechanism of this effect. Int J Hematol 79 (2004) 178-184
6. Huang X.J., Chang Y.J., and Zhao X.Y. In vivo induction of T-cell hyporesponsiveness and alteration of immunological cells of bone marrow grafts using granulocyte colony-stimulating factor. Haematologica 89 (2004) 1517-1524
7. Tayebi H., Kuttler F., Saas P., Lienard A., Petracca B., Lapierre V., et al. Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells. Exp Hematol 29 (2001) 458-470
8. Huang X.J., Chang Y.J., and Zhao X.Y. A direct comparison of immunological characteristics of granulocyte colony-stimulating factor (G-CSF)-primed bone marrow grafts and G-CSF-mobilized peripheral blood grafts. Haematologica 90 (2005) 715-716
9. Lu D.P., Dong L.J., Wu T., Huang X.J., Zhang M.J., Han W., et al. Conditioning including antithymocyte HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 107 (2006) 3065-3073
10. Huang X.J., Han W., Xu L.P., Chen Y.H., Liu D.H., Lu J., et al. A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease. Chin Med J 117 (2004) 1778-1785
11. Bensinger W.I., Martin P.J., Storer B., Clift R., Forman S.J., Negrin R., et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 344 (2001) 175-181
12. Teshima T., and Ferrara J.L.M. Understanding the alloresponse: new approaches to graft-versus-host disease prevention. Semin Hematol 39 (2002) 15-22
13. Falkenburg J.H., Wsfelman A.R., Joosten P., Smit W.M., Van Bergen C.A.M., Bongaerts R., et al. Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood 94 (1999) 1201-1208
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
15. Klangsinsirikul P., and Russell N.H. Peripheral blood stem cell harvest from G-CSF-stimulated donors contain a skewed Th2 CD4 phenotype and a predominance of type 2 dendritic cells. Exp Hematol 30 (2002) 495-501
16. Krenger W., Hill G.R., and Ferrara J.L.M. Cytokine cascades in acute graft-versus-host disease. Transplantation 64 (1997) 553-558
17. Ramsdell F., Seaman M.S., Miller R.E., Picha K.S., Kennedy M.K., and Lynch D.H. Differential ability of Th1 and Th2 cells to express Fas ligand and to undergo activation-induced cell death. Int Immunol 6 (1994) 1545-1553
18. Rissoan M.C., Soumelis V., Kadowaki N., Grouard G., Briere F., Malefyt R.W., et al. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283 (1999) 1183-1186
19. Krenger W., Snyder K.M., Byon J.C., Falzarano G., and Ferrara J.L. Polarized Type 2 alloreactive CD4+ and CD8+ donor T cells fail to induce experimental acute graft-versus-host-disease. J Immunol 155 (1995) 585-593